Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NVO Novo Nordisk A/S daily Stock Chart
NVO [NYSE]
Novo Nordisk A/S
Healthcare | Biotechnology | Denmark
financial highlights | statements
Index- P/E21.86 EPS (ttm)2.40 Insider Own26.40% Shs Outstand1.91B Perf Week-0.10%
Market Cap99.92B Forward P/E18.43 EPS next Y2.85 Insider Trans0.00% Shs Float1.23B Perf Month10.92%
Income5.79B PEG2.38 EPS next Q0.60 Inst Own9.80% Short Float0.21% Perf Quarter-0.40%
Sales17.24B P/S5.79 EPS this Y3.50% Inst Trans0.95% Short Ratio1.87 Perf Half Y13.49%
Book/sh2.99 P/B17.53 EPS next Y14.49% ROA36.00% Target Price53.90 Perf Year17.14%
Cash/sh- P/C- EPS next 5Y9.20% ROE78.30% 52W Range41.23 - 52.83 Perf YTD13.78%
Dividend1.25 P/FCF43.11 EPS past 5Y11.30% ROI73.10% 52W High-0.78% Beta0.60
Dividend %2.38% Quick Ratio0.70 Sales past 5Y6.00% Gross Margin84.10% 52W Low27.14% ATR0.85
Employees42453 Current Ratio1.00 Sales Q/Q8.80% Oper. Margin42.90% RSI (14)68.74 Volatility1.32% 1.32%
OptionableYes Debt/Eq0.09 EPS Q/Q-0.90% Profit Margin33.60% Rel Volume1.56 Prev Close52.19
ShortableYes LT Debt/Eq0.07 EarningsMay 03 BMO Payout339.00% Avg Volume1.39M Price52.42
Recom3.00 SMA206.22% SMA507.10% SMA20010.22% Volume2,179,377 Change0.44%
Jun-11-19Upgrade Barclays Underweight → Equal Weight
Apr-29-19Upgrade Credit Suisse Neutral → Outperform
Jan-29-19Initiated Exane BNP Paribas Outperform
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Dec-29-17Upgrade JP Morgan Underweight → Neutral
Dec-06-17Upgrade BofA/Merrill Neutral → Buy
Dec-01-17Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-25-17Downgrade Exane BNP Paribas Outperform → Neutral
Sep-06-17Upgrade BofA/Merrill Underperform → Neutral
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-31-16Upgrade HSBC Securities Reduce → Hold
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-19-19 09:30AM  NVS or NVO: Which Is the Better Value Stock Right Now? Zacks
Jun-18-19 09:18AM  Novo Nordisk's Victoza Gets FDA Nod for Pediatric Patients Zacks
07:31AM  The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale Benzinga
07:09AM  Shares of cancer-therapy companies skyrocket after Pfizer acquisition news MarketWatch
Jun-17-19 04:01PM  FDA approves non-insulin Type 2 diabetes drug for kids, the first to hit market in 20 years MarketWatch
Jun-14-19 08:42AM  Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod Zacks
Jun-13-19 04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
Jun-12-19 07:01PM  Jim Cramer: A Tale of Two Stocks TheStreet.com
12:11PM  Why This Dow Jones Pharmaceutical Giant Is Trying To Break Out Investor's Business Daily
03:36AM  What Should Investors Know About Novo Nordisk A/S's (CPH:NOVO B) Growth? Simply Wall St.
Jun-11-19 02:45PM  This Pharma Wants To Scoop Its Rivals With An Oral Diabetes Med Investor's Business Daily
02:45PM  CORRECTED-Oral Novo Nordisk diabetes drug poses no more heart risk than placebo -study Reuters
04:30AM  UPDATE 2-China stimulus, German rally help European stock end higher Reuters
Jun-10-19 09:06AM  Eli Lilly Stock Is Falling and Novo Nordisk Is Rising on Diabetes-Drug Results Barrons.com
May-29-19 09:30AM  BMY or NVO: Which Is the Better Value Stock Right Now? Zacks
May-28-19 04:02PM  Gilead Gains 6.8% YTD as HIV Franchise Maintains Momentum Zacks
May-23-19 09:08AM  Lilly (LLY) Launches Half-Priced Version of Humalog Insulin Zacks
May-13-19 07:58AM  Do You Know What Novo Nordisk A/S's (CPH:NOVO B) P/E Ratio Means? Simply Wall St.
May-10-19 07:34AM  Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug Zacks
May-09-19 03:48PM  Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug Motley Fool
May-03-19 03:31PM  Novo Nordisk A/S (NVO) Q1 2019 Earnings Call Transcript Motley Fool
11:37AM  Novo Nordisk (NVO) Q1 Earnings and Revenues Miss Estimates Zacks
10:45AM  Gilead (GILD) Earnings Beat, Revenues Miss Estimates in Q1 Zacks
07:49AM  The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen Benzinga
May-02-19 10:02AM  What's in the Cards for AEterna (AEZS) This Earnings Season? Zacks
08:30AM  Why Earnings Season Could Be Great for Novo Nordisk (NVO) Zacks
12:23AM  Strongbridge Biopharma (SBBP) Q1 2019 Earnings Call Transcript Motley Fool
May-01-19 11:12AM  Strongbridge Biopharma plc (SBBP) Q1 2019 Earnings Call Transcript Motley Fool
09:34AM  Can Allergan (AGN) Beat Earnings Estimates Again in Q1? Zacks
Apr-30-19 12:15PM  Renewable electricity to completely power Novo Nordisk US operations in early 2020 PR Newswire
08:32AM  What's in Store for ANI Pharmaceuticals (ANIP) Q1 Earnings? Zacks
08:02AM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
Apr-29-19 04:41PM  Arcus (RCUS) to Report Q1 Earnings: What's in the Cards? Zacks
10:53AM  Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-27-19 08:16AM  2 Reasons Gilead Sciences' NASH Program Could Bounce Back Motley Fool
Apr-26-19 04:07PM  Will HIV Franchise Sales Drive Gilead's (GILD) Q1 Earnings? Zacks
Apr-25-19 02:55PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
Apr-24-19 04:45PM  Lannett (LCI) to Report Q3 Earnings: What's in the Cards? Zacks
Apr-23-19 09:46AM  Alexion (ALXN) to Report Q1 Earnings: What's in the Cards? Zacks
Apr-22-19 04:42PM  What's in Store for Bayer (BAYRY) This Earnings Season? Zacks
Apr-18-19 09:17AM  Novo Nordisk's (NVO) Share Price Rises YTD on Strong Pipeline Zacks
Apr-17-19 11:03AM  Gilead Collaborates With Insitro to Develop NASH Therapies Zacks
07:48AM  Biotech Stock Roundup: GILD Collaborates on NASH, FCSC Surges on Deal Zacks
Apr-15-19 04:26PM  Gilead to Collaborate with Novo Nordisk for NASH Treatment Zacks
Apr-12-19 07:20AM  Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs TheStreet.com
04:57AM  Novo Nordisk and Gilead team up to test fatty liver disease treatment Reuters
Apr-09-19 01:02AM  Why Fundamental Investors Might Love Novo Nordisk A/S (CPH:NOVO B) Simply Wall St.
Apr-03-19 10:15AM  Sangamo Rises on Positive Phase I/II Hemophilia Study Data Zacks
Mar-29-19 05:41PM  Here is What Hedge Funds Think About Adobe Inc. (ADBE) Insider Monkey
Mar-27-19 03:18PM  Insurance Companies Benefit the Most From Rising Insulin Prices GuruFocus.com
Mar-26-19 02:49PM  Novo Nordisk A/S (NVO): Hedge Funds Are Snapping Up Insider Monkey
Mar-22-19 06:01AM  Bull of the Day: DexCom (DXCM) Zacks
Mar-17-19 03:01AM  Novo Nordisk A/S (CPH:NOVO B): Ex-Dividend Is In 4 Days Simply Wall St.
Mar-06-19 09:24AM  REVIEWAPALOOZA!: 5-Stock Samplers Motley Fool
Mar-05-19 09:00AM  Lilly to Bring Half-Priced Version of Popular Humalog Insulin Zacks
Mar-04-19 08:58AM  What's in the Cards for Aeterna (AEZS) This Earnings Season? Zacks
Mar-01-19 07:00AM  Novo Nordisk files for a label update for Fiasp® to the EMA and the FDA seeking approval for use in children and adolescents PR Newswire
Feb-27-19 10:35AM  Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus Zacks
Feb-26-19 10:44AM  Strongbridge Biopharma plc (SBBP) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-22-19 09:04AM  Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates Zacks
Feb-21-19 10:08AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Feb-20-19 09:53AM  Novo Nordisk Gets FDA Nod for Haemophilia Drug Esperoct Zacks
Feb-12-19 05:30PM  Seattle Genetics' Adcetris Gets EC Nod for Label Expansion Zacks
Feb-11-19 07:30AM  Market Trends Toward New Normal in GameStop, Novo Nordisk A/S, Ferroglobe, PC Connection, Nanometrics, and Anavex Life Sciences Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Feb-07-19 08:32AM  Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth Zacks
02:00AM  [$$] Diabetes pill could inject insulin directly into stomach wall Financial Times
Feb-05-19 03:25PM  Novo Nordisk Is on the Upswing -- for Now Motley Fool
09:53AM  Sanofi's Myeloma Candidate Meets Goal in Phase III Study Zacks
09:19AM  Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer Zacks
Feb-02-19 01:10AM  Novo Nordisk (NVO) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-01-19 01:30PM  Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates Benzinga
12:44PM  [$$] Danish Drugmaker Expects Higher Working Capital as Brexit Looms The Wall Street Journal
12:13PM  Novo Nordisk (NVO) Q4 Earnings Miss Estimates, Revenues Beat Zacks
06:15AM  Novo Nordisk CEO backs ending drug industry rebate system Reuters
05:52AM  Novo Nordisk: 4Q Earnings Snapshot Associated Press
05:08AM  Novo Nordisk's new diabetes drug, outlook lift shares Reuters
04:44AM  Novo Nordisk's new diabetes drug, outlook lift shares Reuters
04:20AM  Novo Nordisk CEO Applauds Trump Plan to Limit Rebates Bloomberg
02:09AM  [$$] Novo Nordisk Net Profit Rise Misses Expectations The Wall Street Journal
Jan-31-19 09:52AM  Eli Lilly (LLY) Q4 Earnings Coming Up: What's in the Cards? Zacks
Jan-30-19 10:57AM  House Democratic leaders probe 3 major drugmakers on insulin prices CNBC
Jan-29-19 09:08AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Jan-28-19 09:55AM  Merck (MRK) Q4 Earnings Coming Up: What's in the Cards? Zacks
Jan-23-19 09:19AM  These 2 Biotech Stocks Seem Significantly Undervalued TheStreet.com
08:00AM  Xultophy® now available in Canada to support improved glycemic control, an issue facing 50 per cent of Canadians with type 2 diabetes CNW Group
Jan-22-19 03:24PM  5 Stocks With High Business Predictability Ratings GuruFocus.com
Jan-21-19 01:33PM  Lilly Stops Lartruvo Promotion as Confirmatory Study Fails Zacks
Jan-15-19 09:30PM  3 Top Diabetes Stocks to Watch in January Motley Fool
Jan-14-19 12:20PM  6 Bargain Stocks With Positive Earnings Growth Estimates GuruFocus.com
12:09PM  House Democrats launch drug-pricing probe into a dozen major health-care companies CNBC
Jan-11-19 05:36PM  5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019 Zacks
Jan-10-19 09:25PM  J&J raises U.S. prices on around two dozen drugs Reuters
06:49AM  [$$] Sanofi and Novo Nordisk press ahead with US insulin prices rises Financial Times
Jan-08-19 06:03PM  Thoughts on 2018 Performance GuruFocus.com
Jan-03-19 09:30AM  Novo Nordisk Boasts Strong Diabetes Presence and Pipeline Zacks
Dec-26-18 02:22PM  6 Valuable Pipeline Drugs With Upcoming Catalysts Benzinga
Dec-22-18 09:00AM  As obesity rates in America soar, new weight loss drugs are in the offing that offer hope CNBC
Dec-19-18 11:15AM  Strongbridge completes $181.7M sale of hormone drug to Novo Nordisk American City Business Journals
12:39AM  Here is What Hedge Funds Think About Novo Nordisk A/S (NVO) Insider Monkey
Dec-18-18 07:17AM  3 Biotechs With Potential Blockbusters Near the Finish Line Motley Fool
Novo Nordisk A/S, a healthcare company, engages in the development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Obesity, and Biopharmaceuticals. The Diabetes Care and Obesity segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral anti-diabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company has a strategic alliance with Evotec AG to discover and develop small molecule therapies to treat patients suffering from diabetes, obesity, and co-morbidities, as well as has a research collaboration with Kallyope Inc. It also has a collaboration agreement Lund University to develop stem cell-derived treatment for Parkinson's diseases; and Staten Biotechnology B.V. to develop novel therapeutics for the treatment of dyslipidaemia. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
open in yahoo | open in reuters | open in google